-
1
المؤلفون: Tomasz Grodzicki, Nikos Werner, A. Benetos, Chakravarthi Rajkumar, Francesco U.S. Mattace-Raso, Timo E. Strandberg, Hugo Clemente, Gulistan Bahat, Athanase Benetos, Marilia Andreia Fernandes, Manuel Martínez-Sellés, Andrea Ungar, Mariana Alves
المساهمون: HUS Internal Medicine and Rehabilitation, Timo Strandberg / Principal Investigator, Department of Medicine, Clinicum, University of Helsinki, Internal Medicine
المصدر: European Geriatric Medicine, 12(4), 725-739. Elsevier Masson
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
European Geriatric Medicineمصطلحات موضوعية: Enfermedad cardiovascular, Angiotensin-Converting Enzyme Inhibitors, 030204 cardiovascular system & hematology, Cardiovascular Diseases / drug therapy, Renin-Angiotensin System, 0302 clinical medicine, RAAS, Renin-Angiotensin System / drug effects, INFECTION, 030212 general & internal medicine, Vitamin D, VITAMIN-D, media_common, RISK, Aspirin, OUTCOMES, Medicamento, Diabetes, ASSOCIATION, NSAID, 3. Good health, PREVALENCE, Antiarrhytmic, Cardiovascular Diseases, Anticoaculant, RECEPTOR BLOCKERS, medicine.drug, Drug, medicine.medical_specialty, Statin, medicine.drug_class, media_common.quotation_subject, Infecciones por coronavirus, Anciano, Angiotensin Receptor Antagonists, Special Article, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Diabetes mellitus, medicine, Coagulopathy, Humans, DRUGS, Intensive care medicine, Pandemics, Aged, Polypharmacy, SARS-CoV-2, business.industry, SARS-CoV-2 / pathogenicity, COVID-19, Angiotensin Receptor Antagonists / therapeutic use, HCC MED, medicine.disease, STATIN USE, COVID-19 Drug Treatment, CONVERTING ENZYME-INHIBITORS, 3121 General medicine, internal medicine and other clinical medicine, Propensity score matching, SARS-CoV-2 / isolation & purification, Observational study, business, Colchicine, Angiotensin-Converting Enzyme Inhibitors / therapeutic use, COVID-19 / diagnosis
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5564a5931a92682c9b30360bae9fc50a
https://ruj.uj.edu.pl/xmlui/handle/item/278330 -
2
المؤلفون: Martin Konrad, David H. Ellison, Shih-Hua Lin, Rosa Vargas-Poussou, Anne Blanchard, Olivier Devuyst, Detlef Bockenhauer, Davide Bolignano, Lorenzo A. Calò, Nine V A M Knoers, Fiona E. Karet Frankl, Etienne Cosyns
المساهمون: University of Zurich, Devuyst, Olivier, Blanchard, Anne [0000-0002-0815-0586], Bolignano, Davide [0000-0003-3032-245X], Ellison, David H [0000-0003-2915-265X], Apollo - University of Cambridge Repository, CIC - HEGP (CIC 1418), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), Paris-Centre de Recherche Cardiovasculaire (PARCC (UMR_S 970/ U970)), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), University College of London [London] (UCL), Great Ormond Street Hospital for Children [London] (GOSH), Consiglio Nazionale delle Ricerche / National Research Council [Calabria, Italy] (CNR), Universita degli Studi di Padova, Wanze [Belgium], Universität Zürich [Zürich] = University of Zurich (UZH), Oregon Health and Science University [Portland] (OHSU), University of Cambridge [UK] (CAM), Cambridge University Hospitals - NHS (CUH), University Medical Center [Utrecht], University Hospital Münster - Universitaetsklinikum Muenster [Germany] (UKM), National Taiwan University [Taiwan] (NTU), Centre de Référence des Maladies Rénales Héréditaires de l'Enfant et de l'Adulte (MARHEA), CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Università degli Studi di Padova = University of Padua (Unipd), Centre de Référence des Maladies Rénales Héréditaires de l'Enfant et de l'Adulte [CHU-Necker] (MARHEA), HULOT, Jean-Sébastien
المصدر: Kidney International, 91(1), 24-33. ELSEVIER SCIENCE INC
Kidney International, 91(1), 24. Nature Publishing Group
Kidney International
Kidney International, Nature Publishing Group, 2017, 91 (1), pp.24-33. ⟨10.1016/j.kint.2016.09.046⟩
Kidney International, 2017, 91 (1), pp.24-33. ⟨10.1016/j.kint.2016.09.046⟩مصطلحات موضوعية: Calcium/urine, Sodium Chloride, Dietary/therapeutic use, Consensus Development Conferences as Topic, 030232 urology & nephrology, Anti-Inflammatory Agents, Angiotensin-Converting Enzyme Inhibitors, Disease, 030204 cardiovascular system & hematology, Sodium Chloride, thiazide-sensitive sodium-chloride cotransporter, [SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology, 10052 Institute of Physiology, 0302 clinical medicine, Gitelman Syndrome/complications, Diagnosis, salt-losing tubulopathy, Medicine, Potassium/administration & dosage, Magnesium, Solute Carrier Family 12, Member 3, Ultrasonography, 2727 Nephrology, Magnesium/administration & dosage, medicine.diagnostic_test, Anti-Inflammatory Agents, Non-Steroidal, Dietary/therapeutic use, Bartter Syndrome/blood, Angiotensin Receptor Antagonists/therapeutic use, 3. Good health, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Chondrocalcinosis/etiology, Phenotype, Nephrology, Practice Guidelines as Topic, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use, medicine.symptom, Gitelman Syndrome, medicine.medical_specialty, Non-Steroidal/therapeutic use, Solute Carrier Family 12, Chloride Channels/genetics, 610 Medicine & health, Chondrocalcinosis, Hypokalemia, Hypocalciuria, Diagnosis, Differential, 03 medical and health sciences, hypomagnesemia, Angiotensin Receptor Antagonists, Rare Diseases/genetics, Rare Diseases, Tubulopathy, Chloride Channels, Journal Article, Humans, Genetic Testing, Salt intake, Sodium Chloride, Dietary, Intensive care medicine, Genetic testing, business.industry, Bartter Syndrome, Gitelman syndrome, medicine.disease, [SDV.MHEP.UN] Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology, hypokalemic metabolic alkalosis, Differential, Member 3/genetics, Dietary Supplements, Mutation, Hypokalemia/blood, Potassium, Quality of Life, 570 Life sciences, biology, Calcium, SLC12A3, Differential diagnosis, Solute Carrier Family 12, Member 3/genetics, business, Kidney disease
وصف الملف: application/pdf; image/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b887761584db08d9bc6a00bdec07adc7
-
3
المؤلفون: Rodrigo A. Fraga-Silva, A. R. Silva, François Mach, Fabrizio Montecucco, Nikolaos Stergiopulos
المصدر: European Journal of Clinical Investigation, Vol. 45, No 3 (2015) pp. 274-87
European journal of clinical investigation
European Journal of Clinical Investigationمصطلحات موضوعية: Pathology, Biological Markers/metabolism, Clinical Biochemistry, Angiotensin-Converting Enzyme Inhibitors, Apoptosis, Coronary Artery Disease, 030204 cardiovascular system & hematology, Bioinformatics, Biochemistry, Angiotensins/antagonists & inhibitors/physiology, Renin-Angiotensin System, 0302 clinical medicine, Medicine, Rupture, Spontaneous/etiology, Myocardial infarction, ddc:616, 0303 health sciences, Receptors, Angiotensin, Neovascularization, Pathologic, Plaque rupture, Apoptosis/physiology, General Medicine, Pathophysiology, Angiotensin Receptor Antagonists/therapeutic use, Plaque, Atherosclerotic, 3. Good health, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Animal studies, medicine.symptom, Coronary Thrombosis/etiology, medicine.medical_specialty, Angiotensins, Cell Proliferation/physiology, Neovascularization, Pathologic/etiology, Inflammation, Arteritis/etiology, Acute coronary syndromes, Receptors, Angiotensin/physiology, 03 medical and health sciences, Angiotensin Receptor Antagonists, Coronary Artery Disease/etiology, Renin–angiotensin system, Humans, 030304 developmental biology, Cell Proliferation, Renin-Angiotensin System/drug effects/physiology, Arteritis, Rupture, Spontaneous, business.industry, Coronary Thrombosis, angiotensin, medicine.disease, Clinical trial, Search terms, atherosclerosis, business, Plaque, Atherosclerotic/etiology, Biomarkers
-
4
المؤلفون: De Bruyne B, Fearon WF, Pijls NH, Tonino P, Piroth Z, Jagic N, Mobius Winckler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engstr?m T, Oldroyd K, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Limacher A, N?esch E, J?ni P, FAME 2 Trial Investigators, BARBATO, EMANUELE
المساهمون: Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Institut National de la Recherche Agronomique (INRA), De Bruyne, B, Fearon, Wf, Pijls, Nh, Barbato, Emanuele, Tonino, P, Piroth, Z, Jagic, N, Mobius Winckler, S, Rioufol, G, Witt, N, Kala, P, Maccarthy, P, Engstr?m, T, Oldroyd, K, Mavromatis, K, Manoharan, G, Verlee, P, Frobert, O, Curzen, N, Johnson, Jb, Limacher, A, N?esch, E, J?ni, P, Fame, 2 Trial Investigators, Cardiovascular Biomechanics
المصدر: New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2014, 371 (13), pp.1208-17. ⟨10.1056/NEJMoa1408758⟩
De Bruyne, Bernard; Fearon, William F; Pijls, Nico H J; Barbato, Emanuele; Tonino, Pim; Piroth, Zsolt; Jagic, Nikola; Mobius-Winckler, Sven; Riouffol, Gilles; Witt, Nils; Kala, Petr; MacCarthy, Philip; Engström, Thomas; Oldroyd, Keith; Mavromatis, Kreton; Manoharan, Ganesh; Verlee, Peter; Frobert, Ole; Curzen, Nick; Johnson, Jane B; ... (2014). Fractional Flow Reserve–Guided PCI for Stable Coronary Artery Disease. New England journal of medicine NEJM, 371(13), pp. 1208-1217. Massachusetts Medical Society MMS 10.1056/NEJMoa1408758 <http://dx.doi.org/10.1056/NEJMoa1408758>
FAME 2 Trial Investigators 2014, ' Fractional flow reserve-guided PCI for stable coronary artery disease ', New England Journal of Medicine, vol. 371, no. 13, pp. 1208-1217 . https://doi.org/10.1056/NEJMoa1408758
The New England Journal of Medicine, 371(13), 1208-1217. Massachussetts Medical Societyمصطلحات موضوعية: Coronary Disease/drug therapy/mortality/physiopathology/*therapy, medicine.medical_specialty, medicine.medical_treatment, Fractional Flow Reserve, [SDV]Life Sciences [q-bio], 610 Medicine & health, Fractional flow reserve, Kaplan-Meier Estimate, Revascularization, Coronary artery disease, 360 Social problems & social services, Internal medicine, medicine, Myocardial Infarction/epidemiology/prevention & control, Humans, Myocardial, Myocardial infarction, Instantaneous wave-free ratio, Proportional Hazards Models, business.industry, Hazard ratio, Percutaneous coronary intervention, General Medicine, medicine.disease, Adrenergic beta-Antagonists/therapeutic use, Combined Modality Therapy, Angiotensin Receptor Antagonists/therapeutic use, 3. Good health, Surgery, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Conventional PCI, Cardiology, Percutaneous Coronary Intervention/adverse effects/*methods, business
وصف الملف: application/pdf
-
5
المؤلفون: Raymond Vanholder, Pierre Cochat, Andrzej Wiecek, Wim Van Biesen, Francis Verbeke, Gérard M. London, Elisabeth Lindley, Denis Fouque, Lucas Van Bortel
المساهمون: Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hospices Civils de Lyon (HCL), Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Institut National de la Recherche Agronomique (INRA)
المصدر: Nephrology Dialysis Transplantation
Nephrology Dialysis Transplantation, Oxford University Press (OUP), 2014, 29 (3), pp.490-6. ⟨10.1093/ndt/gft321⟩
Europe PubMed Centralمصطلحات موضوعية: Male, medicine.medical_specialty, medicine.drug_class, medicine.medical_treatment, [SDV]Life Sciences [q-bio], Population, Angiotensin-Converting Enzyme Inhibitors, Blood Pressure, urologic and male genital diseases, Nephropathy, Angiotensin Receptor Antagonists, Renal Dialysis, Diabetes mellitus, Medicine, Humans, Renal Insufficiency, Renal Insufficiency, Chronic, Intensive care medicine, Antihypertensive drug, education, Angiotensin Receptor Antagonists/*therapeutic use, Antihypertensive Agents, Aged, Transplantation, education.field_of_study, business.industry, Disease Management, Guideline, Middle Aged, medicine.disease, Hypertension/*drug therapy/prevention & control, Quality Improvement, 3. Good health, Blood pressure, Nephrology, Hypertension, Practice Guidelines as Topic, Angiotensin-Converting Enzyme Inhibitors/*therapeutic use, Female, Chronic/physiopathology/*therapy, Hemodialysis, business, Antihypertensive Agents/*therapeutic use, Kidney disease
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71675383204b6ba277446005a1a0940f
https://hal.archives-ouvertes.fr/hal-01859005 -
6
المؤلفون: Fabrizio Montecucco, Nathan Artom, François Mach, Franco Dallegri, Aldo Pende
المصدر: European journal of clinical investigation
European Journal of Clinical Investigation, Vol. 44, No 2 (2014) pp. 219-230مصطلحات موضوعية: Angiotensin receptor, Clinical Biochemistry, MEDLINE, Angiotensin II Receptor Blockers, Pharmacology, Peptidyl-Dipeptidase A, Vascular Remodeling, Bioinformatics, Biochemistry, Receptor, Angiotensin, Type 2, Receptors, G-Protein-Coupled, Peptidyl-Dipeptidase A/biosynthesis, Receptor, Angiotensin, Type 2/physiology, Angiotensin Receptor Antagonists, Acute Coronary Syndrome/drug therapy, Risk Factors, Receptors, G-Protein-Coupled/physiology, Renin–angiotensin system, medicine, Humans, Myocardial infarction, cardiovascular diseases, Acute Coronary Syndrome, ddc:616, Clinical Trials as Topic, Vascular Remodeling/physiology, Angiotensin II receptor type 1, business.industry, General Medicine, medicine.disease, Angiotensin Receptor Antagonists/therapeutic use, Pathophysiology, 3. Good health, Clinical trial, Angiotensin-Converting Enzyme 2, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f9517840b425bb6d4d6f203081a1055